Maryland State Retirement & Pension System’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$972K Sell
3,764
-10
-0.3% -$2.66K 0.02% 501
2025
Q4
$930K Buy
3,774
+69
+2% +$14.5K 0.02% 524
2025
Q3
$654K Sell
3,705
-3,769
-50% -$564K 0.01% 668
2025
Q2
$1.03M Buy
7,474
+123
+2% +$18.1K 0.02% 558
2025
Q1
$1.33M Sell
7,351
-1,172
-14% -$197K 0.03% 422
2024
Q4
$1.34M Sell
8,523
-15
-0.2% -$2.66K 0.03% 490
2024
Q3
$1.55M Sell
8,538
-125
-1% -$24.1K 0.03% 438
2024
Q2
$1.59M Buy
+8,663
New +$1.45M 0.03% 466

Other funds holding KRYS

Maryland State Retirement & Pension System's KRYS Position: Q1 2026 in Review

Maryland State Retirement & Pension System reduced its Krystal Biotech (KRYS) stake by 0.26% in Q1 2026, selling an estimated $2.66K and leaving 3,764 shares worth $972K. The position accounts for 0.02% of the portfolio, ranked #501.

Maryland State Retirement & Pension System first reported a position in KRYS in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.59M in Q2 2024. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Maryland State Retirement & Pension System held 3,764 shares of Krystal Biotech worth $972K as of Q1 2026.
  • Maryland State Retirement & Pension System sold 10 Krystal Biotech shares in Q1 2026, an estimated $2.66K.
  • Krystal Biotech made up 0.02% of Maryland State Retirement & Pension System's portfolio in Q1 2026, its #501 holding.
  • Maryland State Retirement & Pension System first reported a position in Krystal Biotech in Q2 2024 and has held it in 8 quarters since.
  • Maryland State Retirement & Pension System's Krystal Biotech position peaked at $1.59M in Q2 2024.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q1 2026, filed 4 May 2026.